Hypoxia-inducible factor 1α (HIF-1α) correlated with tumor growth and apoptosis in ovarian cancer

International Journal of Gynecological Cancer

Volumn 16, Issue SUPPL. 1, 2006, Pages 405-412

  Jiang, H ^a   Feng, Y ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; HIF 1 ; Ovarian cancer; VEGF

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PACLITAXEL; PROTEIN BCL 2; PROTEIN KINASE INHIBITOR; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INOCULATION; MICROVASCULATURE; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; UPREGULATION; XENOGRAFT;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICROCIRCULATION; MUSCLE, SMOOTH; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; OVARY; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2; SIROLIMUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33645376457     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00310.x     Document Type: Article

References (21)

1. Murdoch WJ. Ovarian surface epithelium ovulation and carcinogenesis. Biol Rev Camb Philos 1996 71 529 43.
2. Wang GL Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995 270 1230 7.
3. Zhong H De Marzo AM Laughner E et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999 59 5830 5.
4. Dvorak HF Browm LF Detmar M Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995 146 1029 39.
5. Buchler P Reber HA Buchler M et al. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003 26 56 64.
6. Gao N Ding M Zheng JZ et al. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem 2002 277 31963 71.
7. Ryan HE Poloni M McNulty W et al. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 2000 60 4010 5.
8. Ryan HE Lo J Johnson RS. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 1998 17 3005 15.
9. Krishnamachary B Berg-Dixon S Kelly B et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1α. Cancer Res 2003 63 1138 43.
10. Horiuchi A Imai T Shimizu M et al. Hypoxia-induced changes in the expression of VEGF, HIF-1α and cell cycle-related molecules in ovarian cancer cells. Anticancer Res 2002 22 2697 702.
11. Jiang BH Jiang G Zheng JZ Lu Z Hunter T Vogt PK. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor. Cell Growth Differ 2001 12 363 9.
12. Birner P Schindl M Obermair A Breitenecker G Oberhuber G. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001 7 1661 8.
13. Hudson CC Liu M Chiang GG et al. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002 22 7004 14.
14. Shayesteh L Lu Y Kuo WL et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999 21 99 102.
15. Hu L Hofmann J Lu Y Mills GB Jaffe RB. Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 2002 62 1087 92.
16. Grunwald V DeGraffenried L Russel D Friedrichs WE Ray RB Hidalgo M. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Cancer Res 2002 62 6141 5.
17. Swinson DE Jones JL Cox G Richardson D Harris AL O'Byrne KJ. Hypoxia-inducible factor-1 alpha in non-small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 2004 111 43 50.
18. Volm M Koomagi R. Hypoxia-inducible factor (HIF-1) and its relation to apoptosis and proliferation in lung cancer. Anticancer Res 2002 20 1527 34.
19. Piret JP Mottet D Raes M Michiels C. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci 2002 973 443 7.
20. Calastretti A Bevilacqua A Ceriani C et al. Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase. Oncogene 2001 21 99 102.
21. Shi Y Frankel A Radvanyi LG Penn LZ Miller RG Mills GB. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res 1995 55 1982 8.